Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

BACKGROUND: Reliable biomarkers of apatinib response in gastric cancer (GC) are lacking. We investigated the association between early presence of common adverse events (AEs) and clinical outcomes in metastatic GC patients. PATIENTS AND METHODS: We conducted a retrospective cohort study using data o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xinyang, Qin, Shukui, Wang, Zhichao, Xu, Jianming, Xiong, Jianping, Bai, Yuxian, Wang, Zhehai, Yang, Yan, Sun, Guoping, Wang, Liwei, Zheng, Leizhen, Xu, Nong, Cheng, Ying, Guo, Weijian, Yu, Hao, Liu, Tianshu, Lagiou, Pagona, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584332/
https://www.ncbi.nlm.nih.gov/pubmed/28870253
http://dx.doi.org/10.1186/s13045-017-0521-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584332/
https://www.ncbi.nlm.nih.gov/pubmed/28870253
http://dx.doi.org/10.1186/s13045-017-0521-0

Ejemplares similares